Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| GILD | Gilead Sciences, Inc. | 4.03% | 69.70 | 1.0% | $1071.78m | |
| BIIB | Biogen, Inc. | 0.02% | 336.71 | 1.5% | $665.47m | |
| AMGN | Amgen, Inc. | 0.29% | 222.79 | 1.3% | $550.81m | |
| ILMN | Illumina, Inc. | -1.50% | 295.94 | 3.5% | $414.21m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 0.49% | 246.29 | 1.9% | $346.37m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 1.01% | 403.15 | 2.6% | $345.56m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.59% | 103.14 | 2.0% | $220.13m | |
| A | Agilent Technologies, Inc. | 0.85% | 85.06 | 1.6% | $165.05m | |
| EXAS | EXACT Sciences Corp. | -2.59% | 99.98 | 24.0% | $144.57m | |
| INCY | Incyte Corp. | -2.27% | 80.89 | 2.5% | $113.92m | |
| SGEN | Seattle Genetics, Inc. | -1.12% | 117.00 | 6.1% | $113.16m | |
| BMRN | BioMarin Pharmaceutical, Inc. | 6.13% | 95.16 | 4.3% | $102.95m | |
| MRNA | Moderna, Inc. | -1.67% | 18.23 | 0.0% | $98.70m | |
| XLRN | Acceleron Pharma, Inc. | -0.36% | 94.51 | 6.1% | $91.83m | |
| ALNY | Alnylam Pharmaceuticals, Inc. | -1.57% | 131.03 | 8.7% | $91.49m |
Company Profile
Dermira, Inc. is a biopharmaceutical company, which engages in the provision of therapies for chronic skin conditions. It focuses on the development of therapeutic solutions in medical dermatology to treat skin conditions, such as hyperhidrosis and atopic dermatitis. The company was founded by Thomas G. Wiggans, Eugene Andrew Bauer, Luis C. Peña, and Christopher M. Griffith on August 18, 2010 and is headquartered in Menlo Park, CA.